Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center

Literature on the safety of remdesivir in hospitalized COVID-19 patients with severe renal impairment is limited. We aimed to investigate the safety and effectiveness of remdesivir in this population. We conducted a retrospective cohort study of adult hospitalized COVID-19 patients who received remd...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of medicine (Helsinki) 2024-12, Vol.56 (1), p.2361843-2361843
Hauptverfasser: Chang, Hsuan-Yu, Hsu, Chia-Chen, Hu, Li-Fang, Chou, Chian-Ying, Chang, Yuh-Lih, Lu, Chih-Chia, Chang, Li-Jen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Literature on the safety of remdesivir in hospitalized COVID-19 patients with severe renal impairment is limited. We aimed to investigate the safety and effectiveness of remdesivir in this population. We conducted a retrospective cohort study of adult hospitalized COVID-19 patients who received remdesivir between April 2022 and October 2022. Outcomes were compared between estimated glomerular filtration rate (eGFR)
ISSN:0785-3890
1365-2060
DOI:10.1080/07853890.2024.2361843